Guerbet is a human-scale company that aims to become a new global leader in medical imaging. Pioneer in contrast media with 90 years' experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors. The company offers a comprehensive range of CT scan, Cath Lab, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve patients' diagnosis, prognosis and quality of life. Advancing in innovation solutions, the diagnosis of major diseases (cardiovascular diseases, cancers, diseases of the central nervous system) and interventional radiology while reconciling efficacy and cost containment, are at the heart of Guerbet's mission.

Type
Public
HQ
Villepinte, FR
Founded
1926
Size (employees)
2,521 (est)
Guerbet was founded in 1926 and is headquartered in Villepinte, FR

Guerbet Office Locations

Guerbet has office in Villepinte
Villepinte, FR

Guerbet Metrics

Guerbet Summary

Market capitalization

€1.05 B

Closing share price

€86.4
Guerbet's current market capitalization is €1.05 B.

Guerbet Market Value History

Guerbet Online Presence

Guerbet Company Life

You may also be interested in